CN1207920A - Composite sea-buckthorn oil capsule - Google Patents
Composite sea-buckthorn oil capsule Download PDFInfo
- Publication number
- CN1207920A CN1207920A CN 98103550 CN98103550A CN1207920A CN 1207920 A CN1207920 A CN 1207920A CN 98103550 CN98103550 CN 98103550 CN 98103550 A CN98103550 A CN 98103550A CN 1207920 A CN1207920 A CN 1207920A
- Authority
- CN
- China
- Prior art keywords
- hippophae
- buckthorn
- sea
- oil
- fructus hippophae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000003145 Hippophae rhamnoides Nutrition 0.000 title claims abstract description 25
- 239000002775 capsule Substances 0.000 title claims abstract description 20
- 239000002131 composite material Substances 0.000 title claims abstract description 15
- 240000000950 Hippophae rhamnoides Species 0.000 title 1
- 241000229143 Hippophae Species 0.000 claims abstract description 131
- 229930003944 flavone Natural products 0.000 claims abstract description 41
- 235000011949 flavones Nutrition 0.000 claims abstract description 41
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 39
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract description 39
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 39
- 235000019198 oils Nutrition 0.000 claims abstract description 37
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 17
- 235000003935 Hippophae Nutrition 0.000 claims description 107
- 239000003921 oil Substances 0.000 claims description 35
- 235000013399 edible fruits Nutrition 0.000 abstract description 7
- 238000002156 mixing Methods 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 4
- 235000001014 amino acid Nutrition 0.000 abstract description 4
- 150000001413 amino acids Chemical class 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 239000000284 extract Substances 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 239000011573 trace mineral Substances 0.000 abstract description 3
- 235000013619 trace mineral Nutrition 0.000 abstract description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 3
- 229930182558 Sterol Natural products 0.000 abstract description 2
- 229930003427 Vitamin E Natural products 0.000 abstract description 2
- 229910052791 calcium Inorganic materials 0.000 abstract description 2
- 235000021466 carotenoid Nutrition 0.000 abstract description 2
- 150000001747 carotenoids Chemical class 0.000 abstract description 2
- 230000006870 function Effects 0.000 abstract description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052700 potassium Inorganic materials 0.000 abstract description 2
- 229910052711 selenium Inorganic materials 0.000 abstract description 2
- 150000003432 sterols Chemical class 0.000 abstract description 2
- 235000003702 sterols Nutrition 0.000 abstract description 2
- 210000004881 tumor cell Anatomy 0.000 abstract description 2
- 235000019165 vitamin E Nutrition 0.000 abstract description 2
- 229940046009 vitamin E Drugs 0.000 abstract description 2
- 239000011709 vitamin E Substances 0.000 abstract description 2
- 229910052725 zinc Inorganic materials 0.000 abstract description 2
- -1 carotin Chemical class 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000000452 restraining effect Effects 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 230000004071 biological effect Effects 0.000 description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000010773 plant oil Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000004223 radioprotective effect Effects 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composite sea-buckthorn capsule is prepared by mixing sea-buckthorn seed oil extracted by means of supercritical CO2 process in 20-50 portions, sea-buckthorn fruit residue oil in 10-30 portions, sea-buckthorn fruit oil in 10-30 portions, sea-buckthorn flavone powder in 10-30 portions, and sea-buckthorn flavone extract 10-30 portions, and capsulizing the mixture. Its main components include unsaturated fatty acid, sea-buckthorn total flavone, amino acid, vitamin E, carotin, carotenoid, sterols and trace elements,such as Ca, Fe, Zn, K and Se. It has the main functions of regulating blood lipoid, resisting angicsclerosis, restraining tumor cell, resisting radiation, strengthening immunity, nourishing skin, etc.
Description
The present invention relates to a kind of composite sea-buckthorn oil capsule, composite sea-buckthorn oil capsule is by supercritical CO
2Compound and the soft capsule made of the Oleum Hippophae of extraction and Fructus Hippophae flavone.
Oleum Hippophae is very precious medicinal plant oil, has the immunity of adjusting, radioprotective, antiinflammatory granulation promoting, the anti-ageing pharmacological action of waiting for a long time.Existing Oleum Hippophae capsule is single Fructrs Hippophae seed oil.The Fructus Hippophae flavone powder is the very precious crude drug that extracts from sea buckthorn juice, sarcocarp, is that raw material is made tablet and is used for treating coronary heart disease, angina pectoris with single Fructus Hippophae flavone powder.But this dosage form has been lost the biological activity of a lot of Fructus Hippophaes.Seabuckthorn fruit flavone oral liquid is blood lipid regulation obviously, effectively prevents and treats cardiovascular and cerebrovascular disease such as coronary heart disease, angina pectoris, premature beat.But but the deficiency that this dosage form has mouthfeel, inconvenience to carry.
Chinese patent, application number are 96104896 to disclose a kind of " Guiyuan capsule " though contain Oleum Hippophae in this capsule, and other composition is a Chinese herbal medicine.Fail to make full use of the active ingredient in the Fructus Hippophae.
Purpose of the present invention is exactly at above-mentioned the deficiencies in the prior art, the composite sea-buckthorn oil capsule that provides a kind of biological activity that makes full use of in the Fructus Hippophae to form.
The present invention is with supercritical CO
2Oleum Hippophae, Fructus Hippophae dreg oil and the Oleum Hippophae of extraction are combined with each other with Fructus Hippophae flavone powder, Fructus Hippophae flavone extractum, make composite sea-buckthorn oil capsule.Become more effectively blood lipid regulation, regulate immunity, treatment, prevention coronary heart disease, angina pectoris, cardiovascular and cerebrovascular disease such as premature beat, cerebral thrombosis, cerebral infarction, radioprotective, anti-chemicotherapy, antiinflammatory granulation promoting, antidotal health care medicine.Mouthfeel, problem such as carry also are resolved simultaneously.
Composite sea-buckthorn oil capsule, the soft capsule that can be made into every is 0.25g, 0.45g, 1g is heavy.
The component and the content of composite sea-buckthorn oil capsule are as follows
Fructrs Hippophae seed oil 20-50 part; Fructus Hippophae dreg oil 10-30 part;
Oleum Hippophae 10-30 part; Fructus Hippophae flavone powder 10-30 part;
Fructus Hippophae flavone extractum 10-30 part.
Wherein the weight proportion of each component is: 30 parts of Fructrs Hippophae seed oil, 17 parts of Fructus Hippophae dreg oils, 20 parts of Oleum Hippophaes, 15 parts in Fructus Hippophae flavone powder, 18 parts of Fructus Hippophae flavone extractum.
The preparation of composite sea-buckthorn oil capsule adopts the conventional method uniform mixing to form concrete steps: (1) is earlier with Fructus Hippophae flavone powder and Fructus Hippophae flavone extractum and a small amount of Fructrs Hippophae seed oil or Oleum Hippophae allotment uniform mixing; (2) the more uniform compositions of allotment is made capsule again with behind Fructrs Hippophae seed oil, Fructus Hippophae dreg oil, the Oleum Hippophae uniform mixing.Wherein Fructrs Hippophae seed oil, Oleum Hippophae, Fructus Hippophae flavone powder are can buy on known substance, the market.The Chinese patent patent No. is 93104942, and name is called " preparation method of Fructrs Hippophae seed oil " and also discloses its preparation method, and Chinese patent application numbers 91104383, name is called: the extracting method of the full fruit oil of platymiscium " preparation method also disclosed.Fructus Hippophae dreg oil and Fructus Hippophae flavone extract making method are as described below:
The present invention adopts supercritical CO
2The Fructus Hippophae dreg oil of extraction, its raw material is the marc after Fructus Hippophae is squeezed the juice.Its technological parameter is pressure 20-30 MPa, temperature 40-65 ℃, flow 300-600 kilogram CO
2/ hour.Supercritical CO
2Extraction Fructus Hippophae dreg oil low-temperature extraction, no solvent residue.
The present invention adopts edible ethanol to extract Fructus Hippophae flavone extractum, can be raw material with Fructus Hippophae concentrated juice, sea-buckthorn pomace, Folium Hippophae separately, also three kinds of raw materials can be pressed with equal proportion or arbitrary proportion mixed extraction.Three kinds of raw material mixed extraction are more than the biological activity that single raw material extracts the Fructus Hippophae flavone extractum that obtains.
The present invention has the following advantages:
Fructrs Hippophae seed oil is extremely precious medicinal plant oil, and Fructus Hippophae dreg oil, Oleum Hippophae are very precious medicinal plant oil equally, and they have certain difference on composition, content, and as unsaturated fatty acid, the seed oil content is just much higher than Marc oil, fruit oil; And α-V
E, non-saponifiable matter, carotene, Marc oil is just than seed oil, fruit oil height; And aminoacid, fruit oil is just than seed oil, marc innage.Above-mentioned several Oleum Hippophaes are combined with each other, and it is more complete then to be combined into the Oleum Hippophae biological activity, the Oleum Hippophae that pharmacological action is stronger.
Fructus Hippophae flavone extractum is to be the raw material extraction, to concentrate the Fructus Hippophae flavone extractum made from Fructus Hippophae concentrated juice, sea-buckthorn pomace, Folium Hippophae, and this extractum contains multiple Fructus Hippophae biological activities such as Fructus Hippophae total flavones, aminoacid, betanin, organic acid, trace element.
The present invention is combined with each other multiple Oleum Hippophae and Fructus Hippophae flavone powder, Fructus Hippophae flavone extractum, is about to Fructus Hippophae 100 multiple nutrients, biological activity and is reassembled into nutrition, health care, composite sea-buckthorn oil capsule that therapeutical effect is stronger.Product assembly rationally once more this invention is extracted Fructus Hippophae by different processing methods after, thus the Fructus Hippophae biological activity that need adapt kept to greatest extent with human body.
The Main Ingredients and Appearance of composite sea-buckthorn oil capsule:
Unsaturated fatty acid 〉=40%
Fructus Hippophae total flavones 〉=5mg/g
Aminoacid, vitamin E, carotene, carotenoid, sterols, organic acid, constant and trace element: calcium, ferrum, zinc, potassium, selenium etc.
Main effect:
Scalable blood fat, anti-angiogenic sclerosis, inhibition tumor cell, auxiliary anticancer; Radioprotective, the toxic and side effects of radiotherapy and chemotherapy of alleviating; Enhance immunity function, slow down aging; Antiinflammatory granulation promoting, promotion tissue regeneration and ulcer healing, nourishing the brain and improving intelligence, improvement memory; Moisten skin nutrition.
The invention will be further described below by embodiment, but the present invention is not limited only to these examples.
The component and the content of composite sea-buckthorn oil capsule are as follows:
Embodiment 1:
Fructrs Hippophae seed oil 20kg Fructus Hippophae dreg oil 10kg
Oleum Hippophae 30kg Fructus Hippophae flavone powder 10kg
Fructus Hippophae flavone extractum 30kg.
Embodiment 2:
Fructrs Hippophae seed oil 25kg Fructus Hippophae dreg oil 25kg
Oleum Hippophae 10kg Fructus Hippophae flavone powder 30kg
Fructus Hippophae flavone extractum 10kg.
Embodiment 3:
Fructrs Hippophae seed oil 30kg Fructus Hippophae dreg oil 17kg
Oleum Hippophae 20kg Fructus Hippophae flavone powder 15kg
Fructus Hippophae flavone extractum 18kg.
Embodiment 4:
Fructrs Hippophae seed oil 45kg Fructus Hippophae dreg oil 12kg
Oleum Hippophae 13kg Fructus Hippophae flavone powder 15kg
Fructus Hippophae flavone extractum 15kg.
Embodiment 5:
Fructrs Hippophae seed oil 50kg Fructus Hippophae dreg oil 10kg
Oleum Hippophae 15kg Fructus Hippophae flavone powder 10kg
Fructus Hippophae flavone extractum 15kg.
The manufacture method of above embodiment 1-5 is the same, and raw material is all purchased in love biotechnology development centre, Shanxi.
Adopt the conventional method uniform mixing to form.Concrete steps: (1) is earlier with Fructus Hippophae flavone powder and Fructus Hippophae flavone extractum and a small amount of Fructrs Hippophae seed oil or Oleum Hippophae allotment uniform mixing; (2) the more uniform compositions of allotment is made capsule again with behind Fructrs Hippophae seed oil, Fructus Hippophae dreg oil, the Oleum Hippophae uniform mixing.Every 1g, instructions of taking: every day 2-3 time, each 1-4 grain.
Claims (2)
1, a kind of composite sea-buckthorn oil capsule is characterized in that: its component and content are:
Fructrs Hippophae seed oil 20-50 part; Fructus Hippophae dreg oil 10-30 part;
Oleum Hippophae 10-30 part; Fructus Hippophae flavone powder 10-30 part;
Fructus Hippophae flavone extractum 10-30 part.
2, composite sea-buckthorn oil capsule according to claim 1, wherein the weight proportion of each component is: 30 parts of Fructrs Hippophae seed oil, 17 parts of Fructus Hippophae dreg oils, 20 parts of Oleum Hippophaes, 15 parts in Fructus Hippophae flavone powder, 18 parts of Fructus Hippophae flavone extractum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98103550A CN1063959C (en) | 1998-08-10 | 1998-08-10 | Composite sea-buckthorn oil capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98103550A CN1063959C (en) | 1998-08-10 | 1998-08-10 | Composite sea-buckthorn oil capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1207920A true CN1207920A (en) | 1999-02-17 |
| CN1063959C CN1063959C (en) | 2001-04-04 |
Family
ID=5217979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98103550A Expired - Fee Related CN1063959C (en) | 1998-08-10 | 1998-08-10 | Composite sea-buckthorn oil capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1063959C (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001079355A1 (en) * | 2000-04-12 | 2001-10-25 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food | Separation of carotenoids from fruits and vegetables |
| WO2006107912A1 (en) | 2005-04-05 | 2006-10-12 | Membrane Protective Technologies, Inc. | Reproductive cell system |
| CN100435663C (en) * | 2006-12-18 | 2008-11-26 | 东北虎药业股份有限公司 | Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method |
| CN1730018B (en) * | 2005-08-04 | 2010-07-28 | 成都中医药大学 | A pharmaceutical composition for treating cardiovascular diseases, its preparation method and application |
| CN101878914A (en) * | 2010-06-28 | 2010-11-10 | 崔晓廷 | Seabuckthorn compound oil combined health care products and preparation method thereof |
| US8173177B2 (en) | 2003-09-08 | 2012-05-08 | Genyous Biomed International Inc. | Compositions of botanical extracts for cancer therapy |
| CN103372201A (en) * | 2012-04-23 | 2013-10-30 | 王铁良 | Hard capsule formula and production method thereof |
| CN103584090A (en) * | 2013-10-22 | 2014-02-19 | 山西五台山沙棘制品有限公司 | Xiangzi soft capsule and preparation method thereof |
| CN103800635A (en) * | 2014-03-12 | 2014-05-21 | 邹琳 | Medicinal and edible two-purpose composition for preventing and treating coronary heart disease and preparation method thereof |
| CN103989171A (en) * | 2014-05-26 | 2014-08-20 | 河南科技大学第一附属医院 | Soft capsule with functions of resisting aging and maintaining beauty and keeping young and preparation process thereof |
| CN106072584A (en) * | 2016-07-13 | 2016-11-09 | 大兴安岭超越野生浆果开发有限责任公司 | A kind of lutein ester and the compound edible health care product of Oleum Hippophae |
| CN106753772A (en) * | 2017-02-23 | 2017-05-31 | 甘肃农业大学 | A method for extracting seabuckthorn seed oil at low temperature and compound product |
| CN108157858A (en) * | 2017-12-25 | 2018-06-15 | 大连民族大学 | A kind of compound lozenge of fructus hippophae leaf |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1031108A (en) * | 1987-08-01 | 1989-02-15 | 中国科学院山西煤炭化学研究所 | The method of supercritical extraction Oleum Hippophae |
| CN1051930C (en) * | 1994-11-21 | 2000-05-03 | 中国医学科学院西安分院医药生物技术研究所 | Medicine for regulating endocrine function of woman |
| CN1062429C (en) * | 1998-07-24 | 2001-02-28 | 北京江河沙棘(集团)公司 | Capsule health food containing powdered sea-buckthorn oil and producing method thereof |
-
1998
- 1998-08-10 CN CN98103550A patent/CN1063959C/en not_active Expired - Fee Related
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001079355A1 (en) * | 2000-04-12 | 2001-10-25 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food | Separation of carotenoids from fruits and vegetables |
| US8173177B2 (en) | 2003-09-08 | 2012-05-08 | Genyous Biomed International Inc. | Compositions of botanical extracts for cancer therapy |
| US20130101616A1 (en) * | 2003-09-08 | 2013-04-25 | James Dao | Compositions of botanical extracts for cancer therapy |
| WO2006107912A1 (en) | 2005-04-05 | 2006-10-12 | Membrane Protective Technologies, Inc. | Reproductive cell system |
| US8202558B2 (en) | 2005-04-05 | 2012-06-19 | Membrane Protective Technologies, Inc. | Reproductive cell function preservation system |
| CN1730018B (en) * | 2005-08-04 | 2010-07-28 | 成都中医药大学 | A pharmaceutical composition for treating cardiovascular diseases, its preparation method and application |
| CN100435663C (en) * | 2006-12-18 | 2008-11-26 | 东北虎药业股份有限公司 | Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method |
| CN101878914A (en) * | 2010-06-28 | 2010-11-10 | 崔晓廷 | Seabuckthorn compound oil combined health care products and preparation method thereof |
| CN103372201A (en) * | 2012-04-23 | 2013-10-30 | 王铁良 | Hard capsule formula and production method thereof |
| CN103584090A (en) * | 2013-10-22 | 2014-02-19 | 山西五台山沙棘制品有限公司 | Xiangzi soft capsule and preparation method thereof |
| CN103584090B (en) * | 2013-10-22 | 2015-10-28 | 山西五台山沙棘制品有限公司 | Blood fat reducing soft capsule and preparation method thereof |
| CN103800635A (en) * | 2014-03-12 | 2014-05-21 | 邹琳 | Medicinal and edible two-purpose composition for preventing and treating coronary heart disease and preparation method thereof |
| CN103989171A (en) * | 2014-05-26 | 2014-08-20 | 河南科技大学第一附属医院 | Soft capsule with functions of resisting aging and maintaining beauty and keeping young and preparation process thereof |
| CN103989171B (en) * | 2014-05-26 | 2015-11-11 | 河南科技大学第一附属医院 | A kind of anti-aging beauty-care face-nourishing soft capsules and preparation technology thereof |
| CN106072584A (en) * | 2016-07-13 | 2016-11-09 | 大兴安岭超越野生浆果开发有限责任公司 | A kind of lutein ester and the compound edible health care product of Oleum Hippophae |
| CN106753772A (en) * | 2017-02-23 | 2017-05-31 | 甘肃农业大学 | A method for extracting seabuckthorn seed oil at low temperature and compound product |
| CN108157858A (en) * | 2017-12-25 | 2018-06-15 | 大连民族大学 | A kind of compound lozenge of fructus hippophae leaf |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1063959C (en) | 2001-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6440448B1 (en) | Food supplement/herbal composition for health enhancement | |
| CN1063959C (en) | Composite sea-buckthorn oil capsule | |
| JP4777776B2 (en) | Ginseng preparation using vinegar and method for producing the same | |
| CN101878908A (en) | Seabuckthorn fruit extract combined health care products and preparation method thereof | |
| CN104664527A (en) | Composition with effects of preventing and resisting cancer, resisting radiation and eliminating heavy metals in bodies | |
| KR101844849B1 (en) | composite composition containing hemp-seed oil and kenaf-seed oil and method for producing | |
| Banik et al. | Phytochemistry, health benefits and toxicological profile of Aloe | |
| KR20050109269A (en) | A ginseng preparation using vinegar and process for thereof | |
| EP1637149A1 (en) | Dietary supplement composition for the man | |
| KR102472612B1 (en) | Method for manufacturing beverage composition using chicken feet and herbal medicine | |
| CN101878913A (en) | Seabuckthorn essential oil health care products and preparation method thereof | |
| CN101878914A (en) | Seabuckthorn compound oil combined health care products and preparation method thereof | |
| CN113679051A (en) | Peony polypeptide powder, solid beverage and application thereof | |
| RU2367465C1 (en) | Agent for male sexual function enhancement | |
| KR100706111B1 (en) | Ginseng Preparation Using Vitamin Seed and Method for Preparing the Ginseng | |
| WO2016009021A1 (en) | Dosage form containing fungal components | |
| AHMAD et al. | Phytochemistry, medicinal and nutritional importance of Asparagus racemosus | |
| CN101972449A (en) | Chinese medicinal material earthworm enzyme and peptide compound preparation and preparation method thereof | |
| US20180169071A1 (en) | Nutritional supplement composition | |
| RU2100938C1 (en) | Composition for dragee "pantogram" and method of its production | |
| RU2170099C1 (en) | Curative-prophylactic agent "elixir evalar" | |
| CN107242563A (en) | A kind of fatigue resistant health food and preparation method thereof | |
| US5516516A (en) | Method of preparing muira puama extract and its use for decreasing body fat percentage and increasing lean muscle mass | |
| RU2654868C1 (en) | Nutritional composition | |
| KR20020049249A (en) | Composition for stimulating/inducing hair growth and process for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |